Does the biomarker search paradigm need re-booting?
Open Access
- 27 February 2009
- journal article
- Published by Springer Nature in BMC Urology
- Vol. 9 (1) , 1
Abstract
The clinical problem of bladder cancer is its high recurrence and progression, and that the most sensitive and specific means of monitoring is cystoscopy, which is invasive and has poor patient compliance. Biomarkers for recurrence and progression could make a great contribution, but in spite of decades of research, no biomarkers are commercially available with the requisite sensitivity and specificity. In the post-genomic age, the means to search the entire genome for biomarkers has become available, but the conventional approaches to biomarker discovery are entirely inadequate to yield results with the new technology. Finding clinically useful biomarker panels with sensitivity and specificity equal to that of cystoscopy is a problem of systems biology.Keywords
This publication has 15 references indexed in Scilit:
- Cystatin B As a Tissue and Urinary Biomarker of Bladder Cancer Recurrence and Disease ProgressionClinical Cancer Research, 2009
- Bladder tumor markers: from hematuria to molecular diagnostics – where do we stand?Expert Review of Anticancer Therapy, 2008
- Should we screen for bladder cancer in a high‐risk population?Cancer, 2006
- Economic impact of screening for bladder cancer using bladder tumor markers: A decision analysisUrologic Oncology: Seminars and Original Investigations, 2006
- Urothelial tumorigenesis: a tale of divergent pathwaysNature Reviews Cancer, 2005
- Outcome signature genes in breast cancer: is there a unique set?Bioinformatics, 2004
- The health economics of bladder cancerPharmacoEconomics, 2003
- Current bladder cancer tests: unnecessary or beneficial?Critical Reviews in Oncology/Hematology, 2003
- Diagnosis and management of superficial bladder cancerCurrent Problems in Cancer, 2001
- Biomarker Risk Assessment and Bladder Cancer Detection in a Cohort Exposed to BenzidineJNCI: Journal of the National Cancer Institute, 2001